Literature DB >> 15095767

Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies.

Craig R Ramsay1, Lloyd Matowe, Roberto Grilli, Jeremy M Grimshaw, Ruth E Thomas.   

Abstract

OBJECTIVES: In an interrupted time series (ITS) design, data are collected at multiple instances over time before and after an intervention to detect whether the intervention has an effect significantly greater than the underlying secular trend. We critically reviewed the methodological quality of ITS designs using studies included in two systematic reviews (a review of mass media interventions and a review of guideline dissemination and implementation strategies).
METHODS: Quality criteria were developed, and data were abstracted from each study. If the primary study analyzed the ITS design inappropriately, we reanalyzed the results by using time series regression.
RESULTS: Twenty mass media studies and thirty-eight guideline studies were included. A total of 66% of ITS studies did not rule out the threat that another event could have occurred at the point of intervention. Thirty-three studies were reanalyzed, of which eight had significant preintervention trends. All of the studies were considered "effective" in the original report, but approximately half of the reanalyzed studies showed no statistically significant differences.
CONCLUSIONS: We demonstrated that ITS designs are often analyzed inappropriately, underpowered, and poorly reported in implementation research. We have illustrated a framework for appraising ITS designs, and more widespread adoption of this framework would strengthen reviews that use ITS designs.

Mesh:

Year:  2003        PMID: 15095767     DOI: 10.1017/s0266462303000576

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  207 in total

Review 1.  Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998.

Authors:  Jeremy Grimshaw; Martin Eccles; Ruth Thomas; Graeme MacLennan; Craig Ramsay; Cynthia Fraser; Luke Vale
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

Review 2.  Impact of safety-related regulatory action on clinical practice: a systematic review.

Authors:  Sigrid Piening; Flora M Haaijer-Ruskamp; Jonie T N de Vries; Menno E van der Elst; Pieter A de Graeff; Sabine M J M Straus; Peter G M Mol
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

3.  Mixture Model Segmentation System for Parasagittal Meningioma brain Tumor Classification based on Hybrid Feature Vector.

Authors:  L Arokia Jesu Prabhu; A Jayachandran
Journal:  J Med Syst       Date:  2018-11-03       Impact factor: 4.460

Review 4.  "Profits before people"? A systematic review of the health and safety impacts of privatising public utilities and industries in developed countries.

Authors:  Matt Egan; Mark Petticrew; David Ogilvie; Val Hamilton; Frances Drever
Journal:  J Epidemiol Community Health       Date:  2007-10       Impact factor: 3.710

5.  Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis.

Authors:  T Delory; A De Pontfarcy; A Emirian; F About; B Berdougo; C Brun-Buisson; P Lesprit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-10       Impact factor: 3.267

6.  Incidence of Narcolepsy in Germany.

Authors:  Doris Oberle; Ursula Drechsel-Bäuerle; Irene Schmidtmann; Geert Mayer; Brigitte Keller-Stanislawski
Journal:  Sleep       Date:  2015-10-01       Impact factor: 5.849

Review 7.  Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.

Authors:  Elizabeth K Stevenson; Amanda R Rubenstein; Gregory T Radin; Renda Soylemez Wiener; Allan J Walkey
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

Review 8.  Targeted mass media interventions promoting healthy behaviours to reduce risk of non-communicable diseases in adult, ethnic minorities.

Authors:  Annhild Mosdøl; Ingeborg B Lidal; Gyri H Straumann; Gunn E Vist
Journal:  Cochrane Database Syst Rev       Date:  2017-02-17

9.  Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds.

Authors:  Helen Bergen; Keith Hawton; Elizabeth Murphy; Jayne Cooper; Navneet Kapur; Carol Stalker; Keith Waters
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

Review 10.  Subsidising artemisinin-based combination therapy in the private retail sector.

Authors:  Newton Opiyo; Gavin Yamey; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.